Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1952 1
1955 1
1956 2
1957 2
1958 4
1959 1
1962 3
1963 1
1964 2
1965 2
1966 2
1967 1
1968 1
1969 1
1970 3
1971 4
1972 5
1973 3
1975 4
1976 3
1977 2
1978 6
1979 2
1980 2
1981 5
1982 7
1983 9
1984 7
1985 6
1986 4
1987 4
1989 6
1990 8
1991 4
1992 5
1993 5
1994 6
1995 4
1996 6
1997 8
1998 11
1999 12
2000 15
2001 28
2002 17
2003 24
2004 21
2005 26
2006 36
2007 26
2008 50
2009 55
2010 57
2011 75
2012 61
2013 50
2014 70
2015 95
2016 76
2017 78
2018 90
2019 99
2020 117
2021 140
2022 149
2023 24
Text availability
Article attribute
Article type
Publication date

Search Results

1,482 results
Results by year
Filters applied: . Clear all The following term was not found in PubMed: Dewsbury-Ennis
Page 1
SABINA: An Overview of Short-Acting β2-Agonist Use in Asthma in European Countries.
Janson C, Menzies-Gow A, Nan C, Nuevo J, Papi A, Quint JK, Quirce S, Vogelmeier CF. Janson C, et al. Adv Ther. 2020 Mar;37(3):1124-1135. doi: 10.1007/s12325-020-01233-0. Epub 2020 Jan 24. Adv Ther. 2020. PMID: 31981105 Free PMC article.
We aimed to describe the current burden of SABA use among European individuals with asthma within the SABA use IN Asthma (SABINA) program. METHODS: Prescription and/or dispensing data during 2006-2017 from electronic medical records and/or national patient registries in th …
We aimed to describe the current burden of SABA use among European individuals with asthma within the SABA use IN Asthma (SABINA) pro …
Sabina.
Balsamo M. Balsamo M. Int J Psychoanal. 2011 Dec;92(6):1347-54. doi: 10.1111/j.1745-8315.2011.00462.x. Int J Psychoanal. 2011. PMID: 22212030 No abstract available.
Overuse of short-acting β2-agonists in asthma is associated with increased risk of exacerbation and mortality: a nationwide cohort study of the global SABINA programme.
Nwaru BI, Ekström M, Hasvold P, Wiklund F, Telg G, Janson C. Nwaru BI, et al. Eur Respir J. 2020 Apr 16;55(4):1901872. doi: 10.1183/13993003.01872-2019. Print 2020 Apr. Eur Respir J. 2020. PMID: 31949111 Free PMC article.
Contemporary population-based data on use, risk factors and impact of SABA (over)use on asthma exacerbations and mortality are scarce, prompting initiation of the global SABINA (SABA use IN Asthma) programme. METHODS: By linking data from Swedish national registries, asthm …
Contemporary population-based data on use, risk factors and impact of SABA (over)use on asthma exacerbations and mortality are scarce, promp …
Letter in reply.
Hunziker S, O'Connell KJ, Stockwell D, Burd RS, Marsch S. Hunziker S, et al. J Crit Care. 2019 Jun;51:223-224. doi: 10.1016/j.jcrc.2019.01.018. Epub 2019 Jan 22. J Crit Care. 2019. PMID: 30709561 No abstract available.
Childhood and cultural evolution.
Hartmann IC. Hartmann IC. J Anal Psychol. 2022 Apr;67(2):605-620. doi: 10.1111/1468-5922.12805. J Anal Psychol. 2022. PMID: 35856551
Already in 1912, Sabina Spielrein addressed the transforming and antagonistic movements of life that appear from conception in her work 'Destruction as the cause of coming into being'. ...
Already in 1912, Sabina Spielrein addressed the transforming and antagonistic movements of life that appear from conception in her wo …
Myasthenia Gravis.
Miranda S, Reid DK, John CS. Miranda S, et al. N Engl J Med. 2017 Mar 30;376(13):e25. doi: 10.1056/NEJMc1701027. N Engl J Med. 2017. PMID: 28357848 No abstract available.
Short-acting β2-agonist prescriptions are associated with poor clinical outcomes of asthma: the multi-country, cross-sectional SABINA III study.
Bateman ED, Price DB, Wang HC, Khattab A, Schonffeldt P, Catanzariti A, van der Valk RJP, Beekman MJHI. Bateman ED, et al. Eur Respir J. 2022 May 5;59(5):2101402. doi: 10.1183/13993003.01402-2021. Print 2022 May. Eur Respir J. 2022. PMID: 34561293 Free PMC article.
BACKGROUND: To gain a global perspective on short-acting beta(2)-agonist (SABA) prescriptions and associated asthma-related clinical outcomes in patients with asthma, we assessed primary health data across 24 countries in five continents. METHODS: SABINA III was a cross-se …
BACKGROUND: To gain a global perspective on short-acting beta(2)-agonist (SABA) prescriptions and associated asthma-related clinical outcome …
Descriptive statistics.
Pérez-Vicente S, Expósito Ruiz M. Pérez-Vicente S, et al. Allergol Immunopathol (Madr). 2009 Nov-Dec;37(6):314-20. doi: 10.1016/j.aller.2009.10.005. Allergol Immunopathol (Madr). 2009. PMID: 19945776
1,482 results